Structural analysis of the sixth immunoglobulin-like domain of mouse neural cell adhesion molecule L1 and its interactions with αvβ3, αIIbβ3, and α5β1 integrins

被引:27
作者
Blaess, S [1 ]
Kammerer, RA [1 ]
Hall, H [1 ]
机构
[1] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4065 Basel, Switzerland
关键词
cell adhesion molecule L1; immunoglobulin-like domain; integrins; RGD sites;
D O I
10.1046/j.1471-4159.1998.71062615.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous experiments suggested that the human cell adhesion molecule L1 interacts with different integrins via its sixth immunoglobulin-like domain in an RGD-dependent manner. Here we have described the expression of this domain from early postnatal mouse brain, analyzed the structure of the recombinant protein by circular dichroism and fluorescence spectroscopy, and performed solid-phase binding studies to alpha v beta 3, alpha IIb beta 3, and alpha 5 beta 1 integrins. The domain was found to have the expected P-sheet organization, which was lost in the presence of guanidine hydrochloride. The midpoint of the single-step transition occurred at 1.5 M guanidine hydrochloride. The sixth immunoglobulin-like domain of mouse brain L1 contains two RGD motifs and was found to bind in a concentration-dependent and saturable way to alpha v beta 3, alpha IIb beta 3, and alpha 5 beta 1 integrins, suggesting specific interactions with these ligands. However, only the interaction to alpha v beta 3 could be inhibited in a concentration-dependent manner by an RGD-containing peptide, and the IC50 was determined to be similar to 20 nM. Mutants of the domain, which lack either one or both of the RGD sites, demonstrated that the RGD site comprising residues 562-564 is involved in the interaction to alpha v beta 3, Our findings indicate an RGD-independent mechanism for the interactions to alpha IIb beta 3 and alpha 5 beta 1, as no involvement of any RGD motif could be demonstrated.
引用
收藏
页码:2615 / 2625
页数:11
相关论文
共 57 条
  • [1] [Anonymous], PRINCIPLES FLUORESCE
  • [2] Outline structure of the human L1 cell adhesion molecule and the sites where mutations cause neurological disorders
    Bateman, A
    Jouet, M
    MacFarlane, J
    Du, JS
    Kenwrick, S
    Chothia, C
    [J]. EMBO JOURNAL, 1996, 15 (22) : 6050 - 6059
  • [3] BAYER EA, 1990, METHOD ENZYMOL, V184, P138
  • [4] DROSOPHILA NEUROGLIAN - A MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY WITH EXTENSIVE HOMOLOGY TO THE VERTEBRATE NEURAL ADHESION MOLECULE L1
    BIEBER, AJ
    SNOW, PM
    HORTSCH, M
    PATEL, NH
    JACOBS, JR
    TRAQUINA, ZR
    SCHILLING, J
    GOODMAN, CS
    [J]. CELL, 1989, 59 (03) : 447 - 460
  • [5] DEMONSTRATION OF IMMUNOCHEMICAL IDENTITY BETWEEN THE NERVE GROWTH FACTOR-INDUCIBLE LARGE EXTERNAL (NILE) GLYCOPROTEIN AND THE CELL ADHESION-L1
    BOCK, E
    RICHTERLANDSBERG, C
    FAISSNER, A
    SCHACHNER, M
    [J]. EMBO JOURNAL, 1985, 4 (11) : 2765 - 2768
  • [6] DELANNET M, 1994, DEVELOPMENT, V120, P2687
  • [7] Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin α8β1 receptor interactions with tenascin:: Murine α8β1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C
    Denda, S
    Müller, U
    Crossin, KL
    Erickson, HP
    Reichardt, LF
    [J]. BIOCHEMISTRY, 1998, 37 (16) : 5464 - 5474
  • [8] The L1 adhesion molecule supports alpha v beta 3-mediated migration of human tumor cells and activated T lymphocytes
    Duczmal, A
    Schollhammer, S
    Katich, S
    Ebeling, O
    SchwartzAlbiez, R
    Altevogt, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 232 (01) : 236 - 239
  • [9] L1 adhesion molecule on human lymphocytes and monocytes: Expression and involvement in binding to alpha v beta 3 integrin
    Ebeling, O
    Duczmal, A
    Aigner, S
    Geiger, C
    Schollhamer, S
    Kemshead, JT
    Moller, P
    SchwartzAlbiez, R
    Altevogt, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) : 2508 - 2516
  • [10] EDWARDS JG, 1988, J CELL SCI, V89, P507